<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Insulin has recently been shown to ameliorate damage in models of global <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To determine whether insulin is also neuroprotective in focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, 20 rats were given 2 to 3 IU/kg insulin and 10 did not receive treatment prior to normothermic transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 2 hours at a blood pressure of 60 mm Hg </plain></SENT>
<SENT sid="2" pm="."><plain>To further elucidate whether infarction volume is influenced by variations in blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels within the physiological range, blood <z:chebi fb="105" ids="17234">glucose</z:chebi> was raised in 10 of the insulin-treated animals to levels comparable with the untreated controls </plain></SENT>
<SENT sid="3" pm="."><plain>At 1-week survival, damage was assessed using quantitative neuropathological examination of 25 coronal planes </plain></SENT>
<SENT sid="4" pm="."><plain>It was found that preischemic insulin lowered the mean intraischemic blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level from 8.4 +/- 0.2 mM (mu +/- standard error of the mean) in the control group to 3.4 +/- 0.2 mM and reduced total damage (<z:mpath ids='MPATH_127'>atrophy</z:mpath> plus cortical and striatal <z:mp ids='MP_0001651'>necrosis</z:mp>), expressed as the percentage of the <z:mpath ids='MPATH_458'>normal</z:mpath> hemisphere, from a control of 28.5% +/- 2.9% to 14.5% +/- 1.6% (p &lt; 0.005) </plain></SENT>
<SENT sid="5" pm="."><plain>Coadministration of <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin resulted in a mean intraischemic blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level of 10.1 +/- 0.5 mM, with 27.0% +/- 2.4% total damage (p = 0.96, compared with control) </plain></SENT>
<SENT sid="6" pm="."><plain>Total ischemic damage showed an independent correlation with blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels (r = 0.67, p = 0.0018) </plain></SENT>
<SENT sid="7" pm="."><plain>The findings indicate that insulin benefits transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and that reducing the blood <z:chebi fb="105" ids="17234">glucose</z:chebi> from 8 to 9 mM to the low-<z:mpath ids='MPATH_458'>normal</z:mpath> range of 3 to 4 mM with insulin dramatically reduces subsequent infarction </plain></SENT>
<SENT sid="8" pm="."><plain>The data suggest that the neuroprotective mechanism of insulin action in focal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> is mediated predominantly via alterations in blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels </plain></SENT>
<SENT sid="9" pm="."><plain>In comparison to global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> appears to show only a minor direct central <z:mp ids='MP_0008912'>nervous</z:mp> system effect of insulin </plain></SENT>
<SENT sid="10" pm="."><plain>In clinical situations in which transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> to the hemisphere can be anticipated, insulin-induced <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> of a mild degree may be beneficial </plain></SENT>
</text></document>